Glaxosmithkline Pharma standalone net profit rises 6.29% in the March 2017 quarter
Sales rise 10.93% to Rs 763.43 crore
Net profit of Glaxosmithkline Pharma rose 6.29% to Rs 112.71 crore in the quarter ended March 2017 as against Rs 106.04 crore during the previous quarter ended March 2016. Sales rose 10.93% to Rs 763.43 crore in the quarter ended March 2017 as against Rs 688.18 crore during the previous quarter ended March 2016.For the full year,net profit declined 10.08% to Rs 336.78 crore in the year ended March 2017 as against Rs 374.53 crore during the previous year ended March 2016. Sales rose 6.09% to Rs 2920.79 crore in the year ended March 2017 as against Rs 2753.02 crore during the previous year ended March 2016.
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content